Dr. Kara Long Roche, MD

Dr. Long Roche practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Long Roche's NPI, 1629269642, was assigned on August 6, 2007. Dr. Long Roche graduated from University of North Carolina at Chapel Hill School of Medicine in 2005. Dr. Long Roche holds Maryland license D76309.

Dr. Long Roche's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Long Roche's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Sloan Kettering Cancer Center (MSK), Department of Surgery. Dmand AI also links Dr. Long Roche to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Long Roche practices. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Long Roche's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Long Roche is licensed in Maryland.

Dmand AI lists abdominal adhesion surgery and hysterectomy among the conditions Dr. Long Roche treats.

CMS data shows 171 Medicare services from Dr. Long Roche across 2 procedure codes in 2024, all of them office visits, for 135 Medicare patients. Medicare paid $12,939 for them. Every service was in an office.

CMS counts 135 Medicare patients who saw Dr. Long Roche in 2024. The largest group is 65 to 74, with 75 patients. 75% of them have high cholesterol, and 64% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Long Roche's median patient age at 64, with 95% women.

In 2024, Dr. Long Roche wrote 39 Medicare Part D claims for 14 patients. 97% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $338 in total drug cost. In 2021, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Long Roche for performance year 2024, reported as part of a group. Dr. Long Roche accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Long Roche as offering telehealth. CMS counts 23 procedures of removal of the uterus by Dr. Long Roche, more than 94% of the clinicians it reports for that procedure.

Dmand AI links 62 papers to Dr. Long Roche, published from 2014 to 2022. 2020 was the busiest year, with 12. The most frequent topics are Ovarian Neoplasms, Carcinoma, Ovarian Epithelial and Cytoreduction Surgical Procedures. Dr. Long Roche has published most often in Gynecol Oncol. Dr. Long Roche's most frequent co-authors are Dennis S. Chi, MD, Yukio Sonoda, MD and Nadeem R. Abu-Rustum, MD.

CMS Open Payments shows 31 general payments to Dr. Long Roche from 5 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 77% of the total. Intuitive Surgical, Inc. paid the most, $4,381.

Dmand AI lists 1 award for Dr. Long Roche, most recently CMS Stage 1 EHR in 2013.

Dr. Long Roche graduated from University of North Carolina at Chapel Hill School of Medicine in 2005.

Dr. Long Roche is in network with 13 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.